Ipamorelin Primary uses: Growth hormone release Muscle growth Fat loss Sleep quality Anti-aging Typical dosing: 200-300mcg before bed, 5-7 days per week Often stacked with CJC-1295 Duration: 3-6 months minimum Administration: Subcutaneous injection Special notes: Cleanest GHRP (minimal side effects) No increase in prolactin or cortisol Excellent sleep enhancement Mild hunger increase (less than GHRP-6) See our Ipamorelin vs CJC-1295 comparison for stacking strategies
Avoid sunbathing, exercise, alcohol and cold outdoor activities for six hours after treatment
It is not a standalone weight loss treatment and is not FDA-approved to diagnose, treat, cure, or prevent any disease

Note: TB-500 is far less studied than full-length Thymosin -4, and the following effects are primarily supported for the parent compound: Actin Binding: Sequesters G-actin monomers, regulating cytoskeletal dynamics essential for cell movement (PMID: 22074294 - Thymosin -4) Cell Migration: Enables endothelial cells, keratinocytes, and other repair cells to migrate to injury sites (PMID: 22074294 - Thymosin -4) Anti-inflammatory: Reduces inflammatory cytokines and promotes resolution of inflammation (PMID: 30116499 - Thymosin -4) Matrix Metalloproteinase Regulation: Modulates tissue remodeling enzymes for proper scar formation (PMID: 16607611 - Thymosin -4) Stem Cell Recruitment: May enhance mobilization of stem cells to damaged areas (PMID: 22074294 - Thymosin -4) Complementary Action: BPC-157 establishes the blood supply (angiogenesis) needed for healing, while TB-500 facilitates the cellular migration and tissue remodeling that follows

10.1002/pmic.201800060 518 SantambrogioC.PonziniE.GrandoriR
doi: 10.1096/fba.2024-00151 Dacquin R, Davey RA, Laplace C, et al